论文部分内容阅读
目的观察扶正化瘀经验方联合化疗治疗胃癌的临床疗效。方法 114例胃癌患者随机分为两组。对照组给予化疗;治疗组则在化疗基础上联合扶正化瘀经验方治疗,28d为1个疗程,连续治疗2个疗程后观察两组临床疗效。结果治疗组总有效率明显高于对照组(P<0.05);治疗后两组患者的生活质量均有所改善,治疗组改善程度更为明显(P<0.05);两组肿瘤标志物CA125、CA199、CA724水平均有所下降,治疗组降低幅度更为明显(P<0.05);两组T细胞亚群CD8+水平治疗后明显降低,而CD4+、CD4+/CD8+水平则明显升高,治疗组升高幅度更为明显(P<0.05)。结论扶正化瘀经验方联合化疗能有效改善患者的生活质量,疗效确切,肿瘤及细胞因子改善明显。
Objective To observe the clinical efficacy of Fuzheng Huayu prescription combined with chemotherapy in the treatment of gastric cancer. Methods 114 patients with gastric cancer were randomly divided into two groups. The control group was given chemotherapy. The treatment group was treated with Fuzhenghuayu prescription on the basis of chemotherapy, and 28 days was treated with one course of treatment. After two courses of continuous treatment, the clinical curative effect was observed. Results The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). After treatment, the quality of life of both groups improved, and the improvement rate of the treatment group was more obvious (P <0.05). The tumor markers CA125, CA199, CA724 levels decreased, the treatment group decreased more significantly (P <0.05); two groups of T cell subsets CD8 + levels decreased significantly after treatment, while the CD4 +, CD4 + / CD8 + levels were significantly increased in the treatment group High amplitude is more obvious (P <0.05). Conclusion Fuzhenghuayu prescription combined with chemotherapy can effectively improve the quality of life of patients with effective curative effect, tumor and cytokines improved significantly.